SCHEMBL8117275

SCHEMBL8117275

c1ccc(N(c2ccccc2)c2ncnc3[nH]ncc23)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 2/20 0.71
▸ CHEK1 O14757 1/20 0.58
▸ AURKA O14965 1/20 0.58
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ MAPK1 P28482 2/20 0.53
▸ HTT P42858 2/20 0.50
▸ LMNA P02545 3/20 0.49
▸ RET P07949 1/20 0.47
▸ PI4KA P42356 1/20 0.47
▸ XDH P47989 1/20 0.47
▸ LRRK2 Q5S007 1/20 0.47
▸ PI4K2B Q8TCG2 1/20 0.47
▸ PI4K2A Q9BTU6 1/20 0.47
▸ PI4KB Q9UBF8 1/20 0.47
▸ MAPT P10636 2/20 0.47
▸ SLC29A1 Q99808 1/20 0.47
▸ PTK2 Q05397 1/20 0.44
▸ PDPK1 O15530 1/20 0.44
▸ MKNK1 Q9BUB5 3/20 0.43
▸ ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4939955 0.77 CSF1R (0.57) CSF1RCHEK1AURKAL3MBTL1MAPK1
SCHEMBL9667930 0.75 CSF1R (0.65) CSF1RCHEK1AURKAL3MBTL1MAPK1
SCHEMBL13717980 0.74 CHEK1 (1.00) CSF1RCHEK1AURKAL3MBTL1MAPK1
SCHEMBL14040850 0.73 CSF1R (1.00) CSF1RCHEK1AURKAL3MBTL1MAPK1
SCHEMBL28649439 0.72 CHEK1 (0.65) CSF1RCHEK1AURKAL3MBTL1MAPK1
SCHEMBL8900055 0.70 EGFR (0.69) CSF1RL3MBTL1PI4KALRRK2PI4K2B
Hydrochloric Acid SCHEMBL6039704 0.69 EGFR (0.67) CSF1RMAPK1HTTLMNAPI4KA
SCHEMBL1406620 0.69 MAPK1 (1.00) MAPK1HTTLMNALRRK2SLC29A1
SCHEMBL9006363 0.68 LMNA (0.60) CSF1RCHEK1AURKAL3MBTL1MAPK1
SCHEMBL13250568 0.67 KEAP1 (0.36) CSF1RL3MBTL1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0819129-B1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2000-08-02 — — EP claimed
US-5981533-A INHIBIT THE TYROSINE KINASE ACTIVITY OF THE RECEPTOR FOR EPIDERMAL GROWTH FACTOR AND CAN BE USED IN THE CASE OF EPIDERMAL HYPERPROLIFERATION (PSORIASIS) AND AS ANTI-TUMOR AGENTS NOVARTIS AG (CH) 1999-11-09 — — US claimed
EP-0819129-B1 PYRAZOLE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2000-08-02 — — EP disclosed
US-5981533-A INHIBIT THE TYROSINE KINASE ACTIVITY OF THE RECEPTOR FOR EPIDERMAL GROWTH FACTOR AND CAN BE USED IN THE CASE OF EPIDERMAL HYPERPROLIFERATION (PSORIASIS) AND AS ANTI-TUMOR AGENTS NOVARTIS AG (CH) 1999-11-09 — — US disclosed
Send feedback